John P Bilbrey
CIK 1268386 · Chairman, President and CEO · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HSY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10 HUDSON YARDS
NEW YORK, NY 10001
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CL | Director | 45,444 | $95.29 | $4.33M | -$1.75M | 63 | 2026-10-02 |
| OLAPLEX HOLDINGS, INC. (OLPX) Delisted | Director | 0 | $2.07 | $0 | $661.0K | 8 | 2026-07-07 |
| ELAN | Director | 120,122 | $23.06 | $2.77M | $351.1K | 6 | 2024-12-03 |
| TPR | Director | 47,846 | $116.29 | $5.56M | $448.2K | 9 | 2024-11-15 |
| CPB | Director | 1,797 | $21.42 | $38.5K | $0 | 16 | 2023-09-29 |
| Elanco Animal Health Inc (ELAT) Delisted | Director | 81,579 | $21.32 | $1.74M | $646.0K | 28 | 2023-01-03 |
| HSY | Director | 162,491 | $165.61 | $26.91M | -$40.08M | 45 | 2018-04-03 |
| MKC.V | Director | 19,045 | $47.52 | $905.0K | $0 | 83 | 2015-04-23 |
Recent Filings · Page 6 of 26
260 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-06 | CL | Grant (A) | +273 | $21.2K | EDGAR |
| 2022-07-05 | Elanco Animal Health Inc (ELAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | CPB | Grant (A) | — | $0 | EDGAR |
| 2022-06-02 | Elanco Animal Health Inc (ELAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-13 | Elanco Animal Health Inc (ELAT) Delisted | Buy (P) | +10,000 | $220.3K | EDGAR |
| 2022-05-11 | CL | Grant (A) | +2,317 | $0 | EDGAR |
| 2022-05-03 | Elanco Animal Health Inc (ELAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | Elanco Animal Health Inc (ELAT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | CL | Grant (A) | +283 | $21.3K | EDGAR |
| 2022-04-01 | CPB | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.